Scientific article
Editorial
English

Editorial comment on : Short-acting β 2-agonist use and asthma exacerbations in Swedish children : A SABINA Junior study

Published inPediatric allergy and immunology, vol. 34, no. 1, e13910
Publication date2023-01
Abstract

Comment on : Melén E, Nwaru BI, Wiklund F, de Fine Licht S, Telg G, Maslova E, van der Valk RJP, Tran TN, Ekström M, Janson C. Short-acting β2 -agonist use and asthma exacerbations in Swedish children: A SABINA Junior study. Pediatr Allergy Immunol. 2022 Nov;33(11):e13885. doi: 10.1111/pai.13885. PMID: 36433853; PMCID: PMC9828275.

Keywords
  • Child
  • Humans
  • Sweden / epidemiology
  • Asthma / drug therapy
  • Asthma / epidemiology
  • Bronchodilator Agents / therapeutic use
  • Administration, Inhalation
  • Anti-Asthmatic Agents / therapeutic use
  • Adrenal Cortex Hormones / therapeutic use
Citation (ISO format)
BOCCABELLA, Cristina, KALAYCI, Omer, EIGENMANN, Philippe. Editorial comment on : Short-acting β 2-agonist use and asthma exacerbations in Swedish children : A SABINA Junior study. In: Pediatric allergy and immunology, 2023, vol. 34, n° 1, p. e13910. doi: 10.1111/pai.13910
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0905-6157
8views
0downloads

Technical informations

Creation16/08/2024 06:11:30
First validation20/09/2024 09:13:57
Update time20/09/2024 09:13:57
Status update20/09/2024 09:13:57
Last indexation07/10/2024 00:17:17
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack